OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

401

Citations

25

References

2013

Year

Christopher R. Chapple, Karl‐Dietrich Sievert, Scott MacDiarmid, Vik Khullar, Piotr Radziszewski, Christopher Nardo, Catherine Thompson, Jihao Zhou, Cornelia Haag‐Molkenteller

European Urology

Urological ResearchUrologyVoiding DysfunctionUrinary IncontinencePlacebo-controlled TrialUrogynecologyMedicineOveractive Bladder

References

	Year	Citations

Page 1